A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);胆道肿瘤(Biliary Tract Neoplasms);胆道外科手术(Biliary Tract Surgical Procedures);癌(Carcinoma);脱氧胞苷(Deoxycytidine);无病生存(Disease-Free Survival);可行性研究(Feasibility Studies);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);胰腺切除术(Pancreatectomy);胰腺肿瘤(Pancreatic Neoplasms);危险因素(Risk Factors);紫杉烷类(Taxoids);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1111/hpb.12413
PMID
25800066
发布时间
2022-12-07
- 浏览3

HPB
587-93页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文